• Mashup Score: 0
    The Grand Roundup - 2 day(s) ago

    We are introducing a new way to deliver the most relevant information you need for your patients on the topics that matter most to your clinical practice.

    Tweet Tweets with this article
    • Sign up today for our bi-weekly email covering emerging research, conference news, and guideline updates on general oncology, breast cancer and lung cancer: https://t.co/Yn7x746tB1 https://t.co/M8zAlDAuZQ

  • Mashup Score: 0
    The Grand Roundup - 5 day(s) ago

    We are introducing a new way to deliver the most relevant information you need for your patients on the topics that matter most to your clinical practice.

    Tweet Tweets with this article
    • Sign up today for our bi-weekly email covering emerging research, conference news, and guideline updates on general oncology, breast cancer and lung cancer: https://t.co/Yn7x746tB1 https://t.co/M8zAlDAuZQ

  • Mashup Score: 2

    Adding an immune checkpoint inhibitor to neoadjuvant chemotherapy can improve pathologic complete response rates and may improve survival in patients with muscle-invasive bladder cancer, research suggests.

    Tweet Tweets with this article
    • Neoadjuvant treatment with an ICI and chemotherapy can produce higher rates of pCR than neoadjuvant chemotherapy alone in patients with muscle-invasive #bladdercancer. https://t.co/rRaOZd8037 #blcsm #gucsm